Filing Details

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G/A

 

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

CV Sciences, Inc. (formerly CannaVEST Corp.)

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

126654102

(CUSIP Number)

 

December 31, 2015

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨

Rule 13d-1(b)

ý

Rule 13d-1(c)

¨

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No. 126654102

SCHEDULE 13G

Page 2 of 5

 

1	NAME OF REPORTING PERSON   Michael Mona III
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) □ (b) □
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5	SOLE VOTING POWER   2,359,832
		6	SHARED VOTING POWER   0
		7	SOLE DISPOSITIVE POWER   2,359,832
		8	SHARED DISPOSITIVE POWER   0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   2,359,832
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   □
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   4.5% (1)
12	TYPE OF REPORTING PERSON   IN

 

 

 

CUSIP No. 126654102

SCHEDULE 13G

Page 3 of 5

 

Item 1(a).	Name of Issuer:
	CV Sciences, Inc. (formerly CannaVEST Corp.), a Delaware corporation
Item 1(b).	Address of Issuer’s Principal Executive Offices:
	2688 South Rainbow Boulevard, Suite B
	Las Vegas, Nevada 89146
Item 2(a).	Name of Person Filing:
	Michael Mona III
Item 2(b).	Address of Principal Business Office, or if None, Residence:
	2793 Red Arrow Drive
	Las Vegas, Nevada 89135
Item 2(c).	Citizenship:
	Michael Mona III is a United States citizen.
Item 2(d).	Title of Class of Securities:
	Common Stock, no par value per share (the “Common Stock”)
Item 2(e).	CUSIP Number:
	126654102
Item 3.	If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
	Not applicable.
Item 4.	Ownership.
	(a)	Amount Beneficially Owned:  2,359,832 shares of Common Stock
	(b)	Percent of Class:  4.5% (1)
	(c)	Number of shares as to which such person has:
		(i)	Sole power to vote or to direct the vote:  2,359,832 shares of Common Stock
		(ii)	Shared power to vote or to direct the vote:  0
		(iii)	Sole power to dispose or to direct the disposition of:  2,359,832 shares of Common Stock
		(iv)	Shared power to dispose or to direct the disposition of:  0
Item 5.	Ownership of Five Percent or Less of a Class.
	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  [ü]

 

CUSIP No. 126654102

SCHEDULE 13G

Page 4 of 5

 

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.
	Not applicable.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
	Not applicable.
Item 8.	Identification and Classification of Members of the Group.
	Not applicable.
Item 9.	Notice of Dissolution of Group.
	Not applicable.
Item 10.	Certification.
	(a)	Not applicable.
	(b)	Not applicable
	(c)	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
Explanatory Notes:
	(1)	The percentage set forth in Row 11 of the cover page and this Item 4(b) assumes that 52,643,756 shares of Common Stock were outstanding as of the date of this statement on Schedule 13G/A, based on 52,013,924 shares of Common Stock outstanding as of May 16, 2016, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on May 16, 2016, including the 437,499 option shares held by the Reporting Person which have vested as of the date of this Schedule 13G/A and assuming the vesting of an additional 192,333 option shares held by the Reporting Person which will vest within sixty (60) days of this Schedule 13G/A.

 

 

 

CUSIP No. 126654102

SCHEDULE 13G

Page 5 of 5

 

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: July 25, 2016

 

 

	By: /s/ Michael Mona III
	Michael Mona III